tradingkey.logo
tradingkey.logo
Suchen

Mangoceuticals Inc

MGRX
Zur Watchlist hinzufügen
0.440USD
+0.047+11.93%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
7.47MMarktkapitalisierung
VerlustKGV TTM

Mangoceuticals Inc

0.440
+0.047+11.93%

mehr Informationen über Mangoceuticals Inc Unternehmen

Mangoceuticals, Inc. is focused on developing men’s and women’s health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.

Mangoceuticals Inc Informationen

BörsenkürzelMGRX
Name des UnternehmensMangoceuticals Inc
IPO-datumMar 21, 2023
CEOCohen (Jacob D)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
GeschäftsjahresendeMar 21
Addresse15110 Dallas Pkwy, Suite 600
StadtDALLAS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl75248
Telefon18336264679
Websitehttps://www.mangorx.com/
BörsenkürzelMGRX
IPO-datumMar 21, 2023
CEOCohen (Jacob D)

Führungskräfte von Mangoceuticals Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenny Myers
Dr. Kenny Myers
Independent Non-Executive Director
Independent Non-Executive Director
136.67K
--
Mr. Eugene M. Johnston
Mr. Eugene M. Johnston
Chief Financial Officer
Chief Financial Officer
120.00K
--
Mr. Alex P. Hamilton
Mr. Alex P. Hamilton
Independent Non-Executive Director
Independent Non-Executive Director
3.33K
+49.01%
Mr. Jacob D. Cohen
Mr. Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Lorraine Dalessio, Esq.
Ms. Lorraine Dalessio, Esq.
Independent Non-Executive Director
Independent Non-Executive Director
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
9.05%
Cohen (Jacob D.)
7.75%
Ikarian Capital LLC
0.81%
Myers (Kenny)
0.81%
D'Alessio (Lorraine Pamela)
0.81%
Andere
80.77%
Aktionäre
Aktionäre
Anteil
Armistice Capital LLC
9.05%
Cohen (Jacob D.)
7.75%
Ikarian Capital LLC
0.81%
Myers (Kenny)
0.81%
D'Alessio (Lorraine Pamela)
0.81%
Andere
80.77%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
10.16%
Hedge Fund
9.87%
Investment Advisor
1.43%
Investment Advisor/Hedge Fund
1.09%
Research Firm
0.48%
Andere
76.98%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
37
2.67M
15.75%
+2.15M
2025Q4
30
728.63K
4.73%
+350.56K
2025Q3
27
301.64K
2.21%
-28.95K
2025Q2
38
3.44M
29.63%
+1.40M
2025Q1
35
1.92M
37.79%
+1.11M
2024Q4
34
1.29M
45.58%
-18.06K
2024Q3
32
811.21K
40.72%
-490.52K
2024Q2
27
759.36K
45.89%
-544.02K
2024Q1
26
674.02K
59.33%
-527.17K
2023Q4
22
660.62K
58.15%
-532.64K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Armistice Capital LLC
1.54M
9.98%
+1.54M
--
Dec 31, 2025
Cohen (Jacob D.)
1.30M
8.48%
-500.00K
-27.70%
Jan 05, 2026
Ikarian Capital LLC
138.15K
0.9%
+138.15K
--
Dec 31, 2025
Myers (Kenny)
136.67K
0.89%
--
--
Jan 05, 2026
D'Alessio (Lorraine Pamela)
136.67K
0.89%
--
--
Jan 05, 2026
Johnston (Eugene M)
120.00K
0.78%
-1.00
-0.00%
Jan 05, 2026
Geode Capital Management, L.L.C.
108.32K
0.7%
+20.35K
+23.13%
Dec 31, 2025
Jane Street Capital, L.L.C.
47.50K
0.31%
+47.50K
--
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
Oct 11, 2024
Merger
15→1
KeyAI